Abbott: Hepatitis C trials

The registry lists 15 Hepatitis C studies with Abbott as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 12Phase 2 1No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Lay User Evaluation of the Panbio™ HCV Self-TestNot yet recruitingNCT06605573Not applicable
• Lay User Evaluation of the Panbio™ HCV Self Test in an EU PopulationNot yet recruitingNCT06492018
• Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected SubjectsCompletedNCT01181427Phase 1
• A Study of Single Doses of ABT-072 in Japanese Healthy Male AdultsCompletedNCT01081483Phase 1
• Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Food on the Pharmacokinetics of ABT-072CompletedNCT00982826Phase 1
• Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compared to ABT-072 Capsule FormulationCompletedNCT00947440Phase 1
• Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability of ABT-450 With RitonavirCompletedNCT00931281Phase 1
• A Study of Single Dose of ABT-333 in Healthy Male AdultsCompletedNCT00919490Phase 1
• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of the ABT-333 TabletCompletedNCT00909636Phase 1
• Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety and Tolerability of ABT-450 With RitonavirCompletedNCT00909311Phase 1
• Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulation and Safety, Tolerability and PK Study of Single Doses of ABT-333 in Healthy VolunteersCompletedNCT00895102Phase 1
• A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis CCompletedNCT00890318Phase 1
• A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333CompletedNCT00768690Phase 1
• A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected AdultsCompletedNCT00752687Phase 1
• A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected SubjectsWithdrawnNCT00121017Phase 2